Renalytix Ai Stock Investor Sentiment

RNLX Stock  USD 0.16  0.01  6.67%   
Slightly above 54% of Renalytix's investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Renalytix AI suggests that some traders are interested. Renalytix's investing sentiment can be driven by a variety of factors including economic data, Renalytix's earnings reports, geopolitical events, and overall market trends.
  

Renalytix Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Renalytix can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over a year ago at benzinga.com         
Why Renalytix Stock Is Surging Today
benzinga news
over a year ago at globenewswire.com         
FDA Grants De Novo Marketing Authorization for KidneyIntelX.dkd to Assess Risk of Progressive Kidney...
Macroaxis News: globenewswire.com
over a year ago at benzinga.com         
KidneyIntelX Clinical Decision Impact Validation and Health Economic Data to be Presented at Upcomin...
benzinga news
over a year ago at finance.yahoo.com         
KidneyIntelX Clinical Decision Impact Validation and Health Economic Data to be Presented at Upcomin...
Yahoo News
over a year ago at insidermonkey.com         
Renalytix Plc Q3 2023 Earnings Call Transcript
insidermonkey News
over a year ago at finance.yahoo.com         
Renalytix Plc Q3 2023 Earnings Call Transcript
Yahoo News
over a year ago at globenewswire.com         
Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2023
Macroaxis News: globenewswire.com
over a year ago at news.google.com         
Would Landstar System Benefit from Manufacturing and Industrial Recoveries - Yahoo Finance
Google News at Macroaxis
over a year ago at benzinga.com         
Renalytix to Report Third Quarter Fiscal Year 2023 Financial Results on June 9
benzinga news
over a year ago at news.google.com         
Are ITV shares a screaming buy - Yahoo Eurosport UK
Google News at Macroaxis
over a year ago at news.google.com         
7.8 percent and 6.8 percent dividend yields Should I buy these UK high-dividend stocks - Yahoo Finan...
Google News at Macroaxis
over a year ago at finance.yahoo.com         
Renalytix selects EVERSANA to expand commercialization of KidneyIntelX for Early-Stage Kidney Diseas...
Yahoo News
over a year ago at news.google.com         
If Id invested 1k in HSBC shares 5 years ago, heres how much Id have now - Yahoo Movies UK
Google News at Macroaxis
over a year ago at news.google.com         
4 reasons why the BAE share price could outperform the FTSE 100 this year - Yahoo Eurosport UK
Google News at Macroaxis
over a year ago at benzinga.com         
New Published Real-World Evidence Shows KidneyIntelX Utility
benzinga news
Far too much social signal, news, headlines, and media speculation about Renalytix that are available to investors today. That information is available publicly through Renalytix media outlets and privately through word of mouth or via Renalytix internal channels. However, regardless of the origin, that massive amount of Renalytix data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Renalytix news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Renalytix relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Renalytix's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Renalytix alpha.

Renalytix Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Renalytix AI Eyes Growth with 10M Fundraise and Restructuring - TipRanks
09/30/2024
2
Acquisition by Icahn School Of Medicine At Mount Sinai of 13366750 shares of Renalytix at 0.116 subject to Rule 16b-3
11/01/2024
3
Renalytix plc Reports Financial Results for First Quarter of Fis - GuruFocus.com
11/20/2024

Additional Tools for Renalytix Stock Analysis

When running Renalytix's price analysis, check to measure Renalytix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Renalytix is operating at the current time. Most of Renalytix's value examination focuses on studying past and present price action to predict the probability of Renalytix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Renalytix's price. Additionally, you may evaluate how the addition of Renalytix to your portfolios can decrease your overall portfolio volatility.